Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
Pellegrino F, Stabile A, Sorce G, Quarta L, Robesti D, Cannoletta D, Cirulli G, Barletta F, Scuderi S, Mazzone E, de Angelis M, Brembilla G, De Cobelli F, Salonia A, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: cannoletta d. Eur Urol Focus. 2024 Jul;10(4):634-640. doi: 10.1016/j.euf.2023.10.006. Epub 2023 Oct 19. Eur Urol Focus. 2024. PMID: 37865591
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A, Pellegrino A, Mazzone E, Cannoletta D, de Angelis M, Barletta F, Scuderi S, Cucchiara V, Gandaglia G, Raggi D, Necchi A, Karakiewicz P, Montorsi F, Briganti A. Stabile A, et al. Among authors: cannoletta d. Eur Urol Oncol. 2022 Feb;5(1):1-17. doi: 10.1016/j.euo.2021.08.001. Epub 2021 Sep 17. Eur Urol Oncol. 2022. PMID: 34538770 Review.
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
Barletta F, Stabile A, Mazzone E, Brembilla G, Sorce G, Pellegrino F, Scuderi S, Cannoletta D, Cirulli GO, Cucchiara V, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Barletta F, et al. Among authors: cannoletta d. Urol Oncol. 2022 Mar;40(3):103.e17-103.e24. doi: 10.1016/j.urolonc.2021.09.015. Epub 2021 Oct 27. Urol Oncol. 2022. PMID: 34688534
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?
Stabile A, Sorce G, Barletta F, Brembilla G, Mazzone E, Pellegrino F, Cannoletta D, Cirulli GO, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Stabile A, et al. Among authors: cannoletta d. World J Urol. 2023 Nov;41(11):3231-3237. doi: 10.1007/s00345-023-04365-4. Epub 2023 Mar 21. World J Urol. 2023. PMID: 36943477
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Pellegrino F, Stabile A, Sorce G, Mazzone E, Cannoletta D, Cirulli GO, Quarta L, Leni R, Robesti D, Brembilla G, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Pellegrino F, et al. Among authors: cannoletta d. Prostate. 2024 Apr;84(5):473-478. doi: 10.1002/pros.24665. Epub 2023 Dec 27. Prostate. 2024. PMID: 38149793
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
Quarta L, Mazzone E, Cannoletta D, Stabile A, Scuderi S, Barletta F, Cucchiara V, Nocera L, Pellegrino A, Robesti D, Leni R, Zaurito P, Brembilla G, De Cobelli F, Samanes Gajate AM, Picchio M, Chiti A, Montorsi F, Briganti A, Gandaglia G. Quarta L, et al. Among authors: cannoletta d. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3789-3798. doi: 10.1007/s00259-024-06789-5. Epub 2024 Jun 11. Eur J Nucl Med Mol Imaging. 2024. PMID: 38861182 Free PMC article. Clinical Trial.
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder.
Robesti D, Moschini M, Pio Tenace N, Burgio G, Re C, Leni R, De Angelis M, Scilipoti P, Pellegrino F, Cannoletta D, Gandaglia G, Fossati N, Gallina A, Doglioni C, Colecchia M, Salonia A, Montorsi F, Briganti A, Lucianò R. Robesti D, et al. Among authors: cannoletta d. Eur Urol Focus. 2024 Jun 26:S2405-4569(24)00096-8. doi: 10.1016/j.euf.2024.06.007. Online ahead of print. Eur Urol Focus. 2024. PMID: 38937195
21 results